Home

Gestational trophoblastic disease

Gestational trophoblastic disease (GTD) is a group of rare diseases in which abnormal trophoblast cells grow inside the uterus after conception. Hydatidiform mole (HM) is the most common type of GTD. Gestational trophoblastic neoplasia (GTN) is a type of gestational trophoblastic disease (GTD) that is almost always malignant Gestational trophoblastic disease (GTD) Gestational trophoblastic disease (GTD) is the name for abnormal cells or tumours that start in the womb from cells that would normally develop into the placenta. They are extremely rare but can happen during or after pregnancy. Most are non cancerous (benign) but some are cancerous Gestational trophoblastic disease (GTD) is a term used for a group of pregnancy-related tumours. These tumours are rare, and they appear when cells in the womb start to proliferate uncontrollably. The cells that form gestational trophoblastic tumours are called trophoblasts and come from tissue that grows to form the placenta during pregnancy Gestational trophoblastic disease (GTD) forms a group of disorders spanning the conditions of complete and partial molar pregnancies through to the malignant conditions of invasive mole, choriocarcinoma and the very rare placental site trophoblastic tumour (PSTT). There are reports of neoplastic transformation of atypical placental site nodules. Most women with gestational trophoblastic disease are of reproductive age. Because the disease is readily treatable with favourable prognosis, fertility becomes an important issue. Hydatidiform mole is a relatively benign disease, and most women do not require chemotherapy after uterine evacuation.

The gestational trophoblastic diseases (GTDs) are a complex family of disorders. The term GTD is a general one, used to describe any of the group of diagnoses that behave out of character from what is expected of gestational trophoblastic tissue. The term GTD refers to both benign and malignant conditions Gestational trophoblastic disease (GTD) comprises a spectrum of disorders from the pre-malignant conditions of complete (CHM) and partial (PHM) hydatidiform moles through to the malignant invasive mole, choriocarcinoma (CC) and very rare placental site trophoblastic tumour/epithelioid trophoblastic tumour (PSTT/ETT)

Gestational Trophoblastic Disease Treatment (PDQ®)-Patient

  1. Gestational trophoblastic disease (GTD) is the name for a rare group of tumors made up of trophoblast cells. They form in the uterus and almost always are related to pregnancy. They can be cancer,..
  2. PERSISTENT GESTATIONAL TROPHOBLASTIC TUMOR 15. PERSISTENT GESTATIONAL TROPHOBLASTIC TUMORA. NONMETASTATIC DISEASE: locally invasive GTT develops in about 15% patients after evacuation of complete mole and infrequently after other gestations
  3. Gestational trophoblastic disease (GTD) is a group of placental related disorders derived from a pregnancy. The incidence of GTD is 1:200-1000 pregnancies, with evidence of ethnic variation; Women from Asia have a higher incidence than non-Asian women (1/390 and 1/750 respectively). The incidence after a live birth is 1/50,000
  4. Gestational trophoblastic disease (GTD) is a spectrum of both benign and malignant gestational tumors, including hydatidiform mole (complete and partial), invasive mole, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor. The latter four entities are referred to as gestational trophoblastic neoplasia (GTN)
  5. Overall, GTD is rare and often curable. In the United States, GTD accounts for less than 1% of all tumors that start in a woman's reproductive system, which is a grouping called gynecologic cancers. GTD occurs in about 1 out of every 1,000 pregnancies in the United States. Most of these are molar pregnancies
  6. Our gestational trophoblastic disease care team is experienced in helping women who are newly diagnosed and those who are facing a repeat occurrence of the disease. In fact, because we are known for treating gestational trophoblastic disease, other hospitals and doctors often refer women with the condition to us for care

Gestational trophoblastic disease is a tumor originating from the trophoblast, which surrounds the blastocyst and develops into the chorion and amnion (see page Placenta and embryo at about 11 4/7 weeks gestation). Gestational trophoblastic disease can occur during or after an intrauterine or ectopic pregnancy estational trophoblastic disease (GTD) is a spectrum of cellular proliferations arising from the placental villous trophoblast encompassing 4 main clinicopathologic forms: hydatidi- form mole (complete and partial), inva- sivemole,choriocarcinoma,andplacen- tal site trophoblastic tumor (PSTT) (Table)

Gestational trophoblastic disease (GTD) is a term used to describe a group of pregnancy-related tumours. They can be divided into two main groups: Pre-malignant conditions (more common) - such as partial molar pregnancy and complete molar pregnancy Gestational trophoblastic disease (GTD) comprises a group of disorders spanning the premalignant conditions of complete and partial molar pregnancies (also known as hydatidiform moles) through to the malignant conditions of invasive mole, choriocarcinoma and the very rare placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic. Gestational trophoblastic tumors (GTT) are malignant forms of gestational trophoblastic disease. The tumor always follows pregnancy, most often molar pregnancy (hydatidiform mole; see this term). Four histological subtypes have been described: invasive mole, gestational choriocarcinoma, placental site trophoblastic tumor and epithelioid. Placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT) are primarily treated with hysterectomy. In the case of disseminated disease, chemotherapy is considered (A). The risk of reoccurrence after trophoblastic disease treated with chemotherapy is approximately 3% Summary. Gestational trophoblastic diseases (GTD) include hydatidiform moles (both complete and partial), invasive moles, and choriocarcinoma.They typically arise from the abnormal fertilization of the ovum. Hydatidiform moles are benign, whereas invasive moles and choriocarcinoma are malignant lesions with a tendency to metastasize to other organs, especially the lungs

Gestational trophoblastic disease (invasive mole) | Image

Gestational trophoblastic disease (GTD) forms a group of disorders spanning the conditions of complete and partial molar pregnancies through to the malignant conditions of invasive mole, choriocarcinoma and the very rare placental site trophoblastic tumour (PSTT). There are reports of neoplastic transformation of atypica 1. What every clinician should know Background. Molar pregnancy and gestational trophoblastic neoplasms (GTNs) comprise a group of interrelated diseases, including complete and partial molar. Gestational trophoblastic disease (GTD) comprises a group of disorders spanning the premalignant conditions of complete and partial molar pregnancies (also known as hydatidiform moles) through to the malignant conditions of invasive mole, choriocarcinoma and the very rare placental site trophoblastic tumour (PSTT) and epithelioi Gestational trophoblastic disease (GTD) comprises a heterogeneous group of related lesions arising from abnormal proliferation of trophoblast of the placenta. The pathogenesis of GTD is unique, because the maternal lesions arise from fetal, not maternal, tissue. The histopathology of GTD is discussed here

Gestational trophoblastic disease (GTD) Cancer Research U

Gestational trophoblastic neoplasia (GTN) is a collective term for gestational trophoblastic diseases that invade locally or metastasize. Hydatidiform mole is the most common form of GTN (see the image below); others are invasive mole (chorioadenoma destruens), choriocarcinoma, placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT) It is also produced by trophoblast cells in gestational trophoblastic diseases (hydatidiform mole, gestational trophoblastic neoplasm (GTN), and choriocarcinoma). hCG is a glycoprotein composed of 2 dissimilar subunits, α- and β-subunit, coded by separate genes on separate chromosomes, held together by charge interactions. hCG α-subunit is. Find a Cancer Type. Choose a cancer type from the list below to get detailed information. If you don't see your type listed, it might be covered under a different name. Use the search icon in the menu at the top of the page, or contact us for help on live chat or by calling 1-800-227-2345. A Gestational trophoblastic disease. Gestational trophoblastic disease (GTD) is a group of pregnancy-related conditions that develop inside a woman's uterus (womb). The abnormal cells start in the tissue that would normally become the placenta. The placenta is the organ that develops during pregnancy to feed the fetus

Gestational trophoblastic disease - Wikipedi

Gestational Trophoblastic Disease: Types of Treatment. Approved by the Cancer.Net Editorial Board, 11/2020. ON THIS PAGE: You will learn about the different types of treatments doctors use to treat GTD. Use the menu to see other pages Gestational trophoblastic disease is a spectrum of interrelated abnormal proliferations of the placental trophoblast, encompassing benign hydatidiform moles (complete and partial) as well as gestational trophoblastic neoplasia, which includes invasive mole, choriocarcinoma, placental site trophoblastic tumor, and its related epithelioid trophoblastic tumor Gestational trophoblastic diseases is used to define the spectrum of disease that has at one extreme benign hydatidiform mole (even prior to evacuation) and at the other, the highly malignant choriocarcinoma. Such diseases indeed form a spectrum, and to understand and adequately manage a patient with one of these conditions requires. Gestational trophoblastic disease is the name for abnormal cells or tumours that grow from the tissue that forms in the womb during pregnancy. It is called GTD for short and is very rare. GTD can be non cancerous (benign) or cancerous (malignant)

134 Gestational Trophoblastic Disease | Radiology Key

Gestational trophoblastic disease (GTD) GTD is a spectrum of diseases that affect women primarily of reproductive age. GTD entities are derived from placental origin, ranging from abnormal. Recent advances in our understanding of the genetics of gestational trophoblastic diseases are stressed. Introductory chapters cover the developmental biology of the placenta and the genetic basis of gestational trophoblastic disease, and one chapter is devoted to the molecular diagnosis of gestational trophoblastic disease

Gestational trophoblastic disease occurs in women during the years when they are able to have children. The female reproductive organs. Gestational trophoblastic disease starts inside the uterus, the hollow, muscular, pear-shaped organ (also called the womb) where a baby grows. The uterus is the main female reproductive organ Gestational trophoblastic disease (GTD) is a spectrum of both benign and malignant gestational tumors, including hydatidiform mole (complete and partial), invasive mole, choriocarcinoma, pla-cental site trophoblastic tumor, and epithelioid trophoblastic tumor. The latter four entities are referred to as gestational trophoblastic neoplasia (GTN)

Gestational Trophoblastic Disease (Green-top Guideline No

Gestational trophoblastic disease (GTD) forms a group of disorders which range from molar pregnancies to malignant conditions such as choriocarcinoma. If there is any evidence of persistence of GTD the condition is referred to as gestational trophoblastic neoplasia (GTN). Cure rates are excellent for this condition The gestational trophoblastic disease occurs in about 1 in every 1000 pregnancies in the United States. Most of these are hydatidiform moles. Choriocarcinoma, the malignant form of Gestational trophoblastic disease (GTD) is even less common, affecting around 2 to 7 of every 100,000 cases in the United States Gestational trophoblastic disease (GTD) is a spectrum of cellular proliferations arising from placental villous trophoblaststhat encompasses four forms: hydatidiform mole ( complete and partial. Gestational trophoblastic disease is a spectrum of interrelated disease processes originating from the placenta (Box 1).Gestational trophoblastic neoplasia refers to lesions that have the potential for local invasion and metastasis. Before the development of sensitive assays for human chorionic gonadotropin (hCG) and effective chemotherapy, mortality from all forms of malignant gestational. First line chemotherapy in low risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev 2009; 1:CD007102. Background: This is an update of a Cochrane review that was first published in Issue 1, 2009. Gestational trophoblastic neoplasia (GTN) is a rare but curable disease arising in the fetal chorion during pregnancy

WHO Scientific Group on Gestational Trophoblastic Diseases & World Health Organization. (‎1983)‎. Gestational trophoblastic diseases : report of a WHO scientific group [‎meeting held in Geneva from 6 to 10 December 1982]‎ Gestational trophoblastic disease encompasses a range of pregnancy-related disorders, consisting of the premalignant disorders of complete and partial hydatidiform mole, and the malignant disorders of invasive mole, choriocarcinoma, and the rare placental-site trophoblastic tumour. These malignant forms are termed gestational trophoblastic. Gestational trophoblastic disease II: classification and DEFINITION management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 2011 Jan;204(1):11-18. Epithelioid trophoblastic tumor (ETT) refers to an unusual type of trophoblastic proliferative disease distinct from placental site trophoblastic tumor and choriocarcinoma with.

Gestational trophoblastic disease (abbreviated GTD), also gestational trophoblastic neoplasia (abbreviated GTN), includes choriocarcinoma and hydatidiform moles. Contents 1 Overvie Complete hydatidiform mole is a gestational trophoblastic disease characterized by diffuse hydropic enlargement and trophoblastic proliferation of the chorionic villi Essential features Proliferative disorder of the placenta, resulting in villous hydrops and trophoblastic hyperplasia without embryonic developmen This book covers the entire spectrum of gestational trophoblastic disease from the most benign to the most malignant form. It addresses etiopathogenesis, molecular basis of the disease, risk assessment, management and follow-up. Management in the form of surgical, medical and supportive care is discussed in detail to help the practitioner in.

Gestational trophoblastic disease (GTD) includes several rare tumours that occur inside the uterus (womb) and start in the cells that form the placenta during pregnancy. Most gestational trophoblastic diseases are non-cancerous. It is estimated that the cancerous forms of GTD make up less than 1% of all women's reproductive system cancers Gestational Trophoblastic Disease (GTD), or Gestational Trophoblastic Tumor, is the name given for a group of diseases characterized by the growth of a tumor within the womb or uterus of women [1].Persistent GTD, marked by persistent increase in beta hCG [3], may be called Gestational Trophoblastic Neoplasia (GTN).Gestational Trophoblastic Disease Classificatio Most women with gestational trophoblastic disease can be successfully managed with preservation of their normal reproductive function. It is important to manage molar pregnancies properly to minimize acute complications and identify malignant sequelae promptly. Current International Federation of Gynecology and Obstetrics (FIGO) guidelines for. World map of Gestational trophoblastic disease Find people with Gestational trophoblastic disease through the map. Connect with them and share experiences. Join the Gestational trophoblastic disease community

Gestational trophoblastic disease - PubMe

Lurain III, JR 2011, ' Gestational trophoblastic disease II: Classification and management of gestational trophoblastic neoplasia ', American journal of obstetrics and gynecology, vol. 204, no. 1, pp. 11-18 Gestational trophoblastic disease (GTD) is a group of tumors that arise from placental tissue and secrete β-hCG. GTD is a combination of benign or invasive mole and malignant known as Gestational.

ACOG Clinical is designed for easy and convenient access to the latest clinical guidance for patient care. Developed with members', physicians', and women's health care professionals' needs in mind, user-friendly features include: Easy, advanced search function to find the most relevant guidance. Enhanced document presentation Gestational trophoblastic disease (GTD) is a general term for rare tumors that form from the tissues surrounding fertilized egg. GTD is often found early and usually cured. Hydatidiform mole (HM) is the most common type of GTD. Explore the links on this page to learn more about GTD treatment and.

Gestational Trophoblastic Disease | Radiology Key

Gestational trophoblastic disease (GTD) and choriocarcinoma, a type of gestational trophoblastic neoplasia (GTN), often show the signs and symptoms of a normal pregnancy. Vaginal bleeding after delivery, miscarriage or abortion that lasts longer than six weeks and shows no signs of stoppin Gestational trophoblastic disease develops when cells related to your pregnancy are cancerous or might become cancerous. It occurs when a placenta forms without a fetus, or with a partial, abnormal fetus. According to the American Cancer Society, gestational trophoblastic disease occurs in about 1 of 1,000 pregnancies in the United States. It. Persistent trophoblastic disease and choriocarcinoma are very rare pregnancy-related tumours known as gestational trophoblastic tumours (GTTs). Persistent trophoblastic disease. In the UK, about 1 in 600 pregnancies are found to be a molar pregnancy, where the foetus and placenta don't form properly and a baby doesn't usually develop The term gestational trophoblastic disease includes hydatidiform moles, invasive hydatidiform moles, and choriocarcinoma. However, many gynaecologists and oncologists seem to consider that these conditions represent a neoplastic spectrum, with moles at the benign end, choriocarcinoma at the malignant extreme, and invasive hydatidiform moles being equivalent to a neoplasm of borderline malignancy Support access to the best possible care for women diagnosed with gestational trophoblastic disease. COLLABORATE. Facilitate provincial and national collaboration for the care of women with gestational trophoblastic disease through a centralized clinical information database

Gestational Trophoblastic Disease - NORD (National

The gestational trophoblastic disease (GTD) service at Charing Cross Hospital is a highly specialist service providing comprehensive registration, screening and clinical management for all forms of the disease. Our internationally renowned GTD team are world leaders in the investigation and treatment of these rare conditions Gestational trophoblastic disease (GTD) is a group of pregnancy-related disorders that arise from abnormal proliferation of placental trophoblast. Some patients with GTD develop hyperthyroidism, a rare but potentially life-threatening complication requiring early detection and management. Existing literature on hyperthyroidism in GTD is scant Gestational Trophoblastic Disease treatment and recurrent disease. GTD is a highly curable disease. Women with hydatidiform mole have an excellent prognosis and rarely need treatment, while women with GTN also have a very good prognosis but require treatment. Choriocarcinoma, for example, is an uncommon — yet almost always curable — cancer Types of Gestational Trophoblastic Disease. There are two main types of GTD: hydatidiform mole (HM), also called molar pregnancy, and gestational trophoblastic neoplasia (GTN). Hydatidiform Mole. Hydatidiform mole (HM) or molar pregnancy is the most common form of GTD. It is most often benign (non-cancerous) and stays in the uterus

GESTATIONAL. TROPHOBLASTIC DISEASE Gestational Trophoblastic Disease (GTD) abnormal growth of tumors inside a woman's uterus that started in the cells that would normally develop in the placenta during pregnancy Trophoblast- layer of cells that surrounds an embryo tropho - means nutrition blast - means bud early developmental cell In normal development, these cells form finger-like. Gestational Trophoblastic Disease. An invasive mole retains hydropic villi, which penetrate the uterine wall. Hydropic villi may embolize to distant organs, but this tumor does not have - PowerPoint PPT presentation. PowerShow.com is a leading presentation/slideshow sharing website Gestational trophoblastic disease (GTD) is a rare group of tumors that develop early in pregnancy. It occurs when abnormal cells grow in the trophoblastic tissue which typically surrounds the fertilized egg. This tissue normally develops into the placenta to support the pregnancy. Hydatidiform mole or mole is the term used to describe the. Gestational trophoblastic disease (GTD) is a group of rare cancers in which abnormal trophoblast cells grow inside the uterus after conception. Hydatidiform mole (HM) is the most common type of GTD. Gestational trophoblastic neoplasia (GTN) is a type of gestational trophoblastic disease (GTD) that is almost always malignant

Gestational trophoblastic disease (GTD) is the name given to a group of rare tumors that develop during early pregnancy. After conception, tissue grows to form part of the placenta and surrounds the fertilized egg in the uterus, forming what's called a trophoblast A group of diseases arising from pregnancy that are commonly associated with hyperplasia of trophoblasts (TROPHOBLAST) and markedly elevated human CHORIONIC GONADOTROPIN. They include HYDATIDIFORM MOLE, invasive mole (HYDATIDIFORM MOLE, INVASIVE), placental-site trophoblastic tumor (TROPHOBLASTIC TUMOR, PLACENTAL SITE), and CHORIOCARCINOMA RESULTS: A significant difference in depression levels was found between women with hydatiform mole and women with gestational trophoblastic neoplasia (p = 0.02). On the contrary, anxiety and depression levels did not vary on the basis of time elapsed since diagnosis, presence of children, and age (< 35 years)

Gestational trophoblastic disease is a tumor originating from the trophoblast, which surrounds the blastocyst and develops into the chorion and amnion (see page Placenta and embryo at about 11 4⁄7 wk gestation). This disease can occur during or after an intrauterine or ectopic pregnancy. If the disease occurs during a pregnancy, spontaneous. Gestational Trophoblastic Disease Definition. The condition refers to a group of tumors that develop inside the uterus in many pregnant women. As the name suggests, the abnormal growths occur in the trophoblast, the outermost layer of the blastocyst that serves as a nutritive pathway for the embryo Gestational trophoblastic diseases are a spectrum of related disorders which consist of benign trophoblastic lesions, premalignant hydatidiform moles, and neopla-stic diseases.1 The incidence of molar pregnancy is in-creasing in South East Asia ranges from 3.2 9.9 / 1000 gestation.2 The incidence of molar pregnancy de-monstrated marked.

Gestational trophoblastic disease (GTD) is a placen-tal disease: it arises from abnormal proliferation of trophoblastic cells in the placenta. When GTD persists or recurs it is often called gestational tropho-blastic neoplasm (GTN). The spectrum of GTD includes: • Complete and partial hydatidiform molar preg Gestational trophoblastic diseases are a group of disorders composed of benign lesions like complete mole, partial mole, invasive mole, exaggerated placental site reaction, placental site nodule and malignant lesions like choriocarcinoma, placental site trophoblastic tumour, epithelioid trophoblastic tumour.M ETT is a very rare tumour, first described by Shih and Kurman in 1998, and so far.

Gestational Trophoblastic Disease (GTD) Overview. The New England Trophoblastic Disease Center at Dana-Farber/Brigham and Women's Cancer Center, affiliated with the Susan F. Smith Center for Women's Cancers , has the greatest experience treating this disease in North America and the largest registry. Our physicians and researchers have been the. Gestational trophoblastic disease (GTD) is a spectrum of placental disorders resulting from abnormal placental trophoblastic growth, ranging from benign molar pregnancies (complete and partial) to neoplastic conditions, such as invasive mole, choriocarcinoma, and placental site trophoblastic tumor (PSTT), depending on their aggressiveness and. This is called persistent gestational trophoblastic neoplasia (GTN). This occurs in about 15% to 20% of complete molar pregnancies, and up to 5% of partial molar pregnancies. One sign of persistent GTN is a high level of human chorionic gonadotropin (HCG) — a pregnancy hormone — after the molar pregnancy has been removed Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol 1995 Nov;59(2):226-30. (25) Hassadia A, Gillespie A, Tidy J, Everard RGNJ, Wells M, Coleman R, et al. Placental site trophoblastic tumour: clinical features and management Gestational trophoblastic disease is a rare form of cancer in women. It happens when the egg and sperm do not combine correctly. Gestational trophoblastic disease starts in the uterus (womb) during the time women can have children. Gestational trophoblastic disease may first occur as a molar pregnancy

Gestational trophoblastic disease: ESMO Clinical Practice

What Is Gestational Trophoblastic Disease

Gestational trophoblastic diseases - SlideShar

PPT - Gestational Trophoblastic Disease PowerPoint

Gestational trophoblastic disease (GTD) comprises a group of rare tumors originating from cells that would normally develop into the placenta during pregnancy. The spectrum of disease includes benign disease (complete hydatidiform mole [CHM] or partial hydatidiform mole [PHM]) and malignant tumors termed gestational trophoblastic neoplasms (GTNs), which encompass invasive mole, gestational. Gestational trophoblastic disease (GTD), or abnormal proliferation of placental trophoblastic tissue, is a rare complication of pregnancy. There is considerable variation in the worldwide distribution of GTD, with the highest frequencies reported in Asia and the Middle East and lower rates on the order of 1 per 1,000 pregnancies i Gestational Trophoblastic Disease Gestational trophoblastic disease at a glance. Gestational trophoblastic disease (GTD) is a group of diseases in which abnormal growths of tissue or tumors occur in the uterus, specifically in the layer of cells surrounding an embryo called the trophoblast that joins the sperm and the egg Gestational trophoblastic disease (GTD) refers to a spectrum of interrelated but histologically distinct tumors originating from the placenta ().These diseases are characterized by a reliable tumor marker, which is the β-subunit of human chorionic gonadotropin (β-hCG), and have varied tendencies for local invasion and spread

Gestational Trophoblastic Disease: Clinical and Imaging

Gestational trophoblastic disease. print Email. Select Species: Disease State Panels. PrimePCR disease state panels were designed by referencing the National Library of Medicine database. Disease state panels allow for the thorough investigation of differentially expressed genes within a specified pathology Gestational Trophoblastic Disease (GTD): An Overview Gestational trophoblastic disease (GTD) is a rare group of interrelated tumors that develop following conception that lead to abnormal development of the placenta. More than 80% of GTD cases are non-cancerous. All forms of GTD can be treated, and in the great majority o What are the types of histological categories of GTD. 1.Benign trophoblastic disease. 2. Hydatidiform mole = complete and partial. 3. Gestational trophoblastic neoplasia encompassing. persistent and invasive mole , gestational choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor Gestational trophoblastic disease. Obstet Gynecol. 2006; 108(1):176-87 (ISSN: 0029-7844) Soper JT. This review summarizes the primary management of molar pregnancies, surveillance after evacuation, and the evaluation and management of malignant gestational trophoblastic neoplasia (GTN)

Gestational Trophoblastic Disease: Statistics Cancer

Metastatic gestational trophoblastic disease: a comparison of prognostic classification systems. Gynecol Oncol 1992; 45:40. Kong Y, Yang J, Jiang F, et al. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study

CHAPTER 37: Gestational Trophoblastic Disease | Obgyn KeyMy Placental Pathology - Pathology And Laboratory MedicineRetained products of conception - wikidocEarly Pregnancy Failure and Ectopic Pregnancy | Obgyn Key